Insider Transactions in Q2 2025 at Eton Pharmaceuticals, Inc. (ETON)
Insider Transaction List (Q2 2025)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 16
2025
|
David Krempa Chief Business Officer |
SELL
Open market or private sale
|
Direct |
10,223
-1.64%
|
$143,122
$14.73 P/Share
|
Jun 13
2025
|
David Krempa Chief Business Officer |
SELL
Open market or private sale
|
Direct |
6,800
-1.08%
|
$95,200
$14.77 P/Share
|
Jun 12
2025
|
David Krempa Chief Business Officer |
SELL
Open market or private sale
|
Direct |
16,977
-2.63%
|
$237,678
$14.92 P/Share
|
Jun 10
2025
|
Opaleye Management Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
7,930
+1.76%
|
$118,950
$15.82 P/Share
|
Jun 05
2025
|
Sean Brynjelsen President & CEO |
SELL
Open market or private sale
|
Direct |
70,000
-2.38%
|
$1,120,000
$16.81 P/Share
|
Jun 04
2025
|
Sean Brynjelsen President & CEO |
SELL
Open market or private sale
|
Direct |
70,000
-2.32%
|
$1,190,000
$17.0 P/Share
|
Jun 03
2025
|
Sean Brynjelsen President & CEO |
SELL
Open market or private sale
|
Direct |
70,000
-0.76%
|
$1,260,000
$18.26 P/Share
|